Literature DB >> 25702669

Identification of new hub genes associated with bladder carcinoma via bioinformatics analysis.

Zhuomin Jia1, Xing Ai, Fengling Sun, Tong Zang, Yawei Guan, Feng Gao.   

Abstract

AIMS AND
BACKGROUND: Bladder carcinoma (BC) is one of the most common malignant cancers worldwide. Several genes related to the mechanism of BC have been studied in recent years, but the current understanding of BC is still rather limited. This study aimed to find new differentially expressed genes (DEGs) associated with the occurrence and development of BC.
METHODS: In this work, we downloaded gene expression data from Gene Expression Omnibus under accession number GSE27448, which included 10 GeneChips from urinary BC tissues and 5 from normal tissues. DEGs were identified by the LIMMA package in R. Then the protein-protein interactions (PPIs) networks were analyzed with the database of Search Tool for the Retrieval of Interacting Genes, and gene ontology (GO) was applied to explore the underlying function of the DEGs using the Database for Annotation, Visualization and Integrated Discovery.
RESULTS: A total of 2,068 DEGs were found between BC and normal tissues. These genes were involved in 49 functional clusters. The top 10 highest degree nodes, such as POLR2F/2H (DNA directed RNA polymerase II polypeptide F/polypeptide H) and RPS14/15 (ribosomal protein S14/S15), were proven to be hub nodes in the PPIs network. ITGA7 (integrin, alpha 7), GRB14 (growth factor receptor-bound protein 14), CDC20 (cell division cycle 20) and PSMB1 (proteasome subunit, beta type, 1) were significant DEGs identified in the functional clusters.
CONCLUSIONS: Genes such as POLR2F/2H, RPS14/15, ITGA7, GRB14, CDC20 and PSMB1 were forecast to play important roles in the occurrence and progression of BC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25702669     DOI: 10.5301/tj.5000196

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


  6 in total

1.  Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis.

Authors:  Chuan Zhang; Mandy Berndt-Paetz; Jochen Neuhaus
Journal:  Diagnostics (Basel)       Date:  2020-01-24

2.  Transcriptome Analysis Reveals Possible Immunomodulatory Activity Mechanism of Chlorella sp. Exopolysaccharides on RAW264.7 Macrophages.

Authors:  Siwei Wu; Hongquan Liu; Siyu Li; Han Sun; Xiumiao He; Ying Huang; Han Long
Journal:  Mar Drugs       Date:  2021-04-14       Impact factor: 5.118

3.  26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.

Authors:  Andres J Rubio; Alfonso E Bencomo-Alvarez; James E Young; Vanessa V Velazquez; Joshua J Lara; Mayra A Gonzalez; Anna M Eiring
Journal:  Cells       Date:  2021-09-11       Impact factor: 6.600

4.  Downregulation of ZNF280A inhibits proliferation and tumorigenicity of colorectal cancer cells by promoting the ubiquitination and degradation of RPS14.

Authors:  Binle Tian; Jingyi Zhou; Guiming Chen; Tao Jiang; Qi Li; Jian Qin
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

5.  Transcriptome profile of the early stages of breast cancer tumoral spheroids.

Authors:  Rosario Pacheco-Marín; Jorge Melendez-Zajgla; Gonzalo Castillo-Rojas; Edna Mandujano-Tinoco; Alfredo Garcia-Venzor; Salvador Uribe-Carvajal; Alfredo Cabrera-Orefice; Carolina Gonzalez-Torres; Javier Gaytan-Cervantes; Irma B Mitre-Aguilar; Vilma Maldonado
Journal:  Sci Rep       Date:  2016-03-29       Impact factor: 4.379

6.  Integrin α7 high expression correlates with deteriorative tumor features and worse overall survival, and its knockdown inhibits cell proliferation and invasion but increases apoptosis in breast cancer.

Authors:  Xiaorong Bai; Chen Gao; Lifeng Zhang; Suisheng Yang
Journal:  J Clin Lab Anal       Date:  2019-07-19       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.